Valproate-induced epileptic tonic status

Seizure

Volumn 7, Issue 3, 1998, Pages 237-241

  Capocchi, G ^a,b   Balducci, A ^a   Cecconi, M ^a   Pelli, M A ^b   Picchiarelli, A ^a   Silvestrelli, G ^a   Zampolini, M ^a  

^a Cattedra di Neurofisiopatologia   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Encephalopathy; Epileptic tonic status; Excitotoxicity; Valproate

Indexed keywords

AMMONIA; PHENOBARBITAL; VALPROIC ACID;

ADOLESCENT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CASE REPORT; DRUG BLOOD LEVEL; EPILEPTIC STATE; HUMAN; LIVER FUNCTION; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; TONIC CLONIC SEIZURE;

EID: 0031879684     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(98)80042-3     Document Type: Article

References (24)

1. Marescaux, C., Warter, J.M., Micheletti, G., Rumbach, L., Coquillat, G., et al. Stuporous episodes during treatment with sodium valproate: report of seven cases. Epilepsia 1982; 23: 297-305.
2. Zaccara, G., Campostrini, R., Paganini, M., Moroni, F., Valenza, T., et al. Acute changes of blood ammonia may predict short term adverse effect of valproic acid. Neurology 1984; 34: 1519-1521.
3. Jeavons, P.M., Clark, J.E., Maheshari, M.C. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ('Epilium'). Developmental Medicine and Child Neurology 1977; 19: 9-25.
4. Dreifuss, F.E., Santilli, N., Langer, D.H., Sweeney, K.P., Moline, K.A., Menader, K.B. Valproic acid hepatic fatalities: A retrospective review. Neurology, 1987; 37: 379-385.
5. Bohan, T.P., Tennison, M.B., Rettenmeiere, A., Baillie, T.A. Valproic acid (VPA) metabolism in a boy with liver failure. Pharmacologist 1987; 29: 179.
6. Zaccara, G., Paganini, M., Campostrini, R., Arnetoli, G., Zappoli, R., et al. Hyperammonemia and valproate-induced alterations of the state of consciousness. European Neurology 1984; 23:104-112.
7. Rawat, S., Borkowsky, W., Swick, H. Valproic acid and secondary hyperammonemia. Neurology 1981; 31:1973-1974.
8. Marescaux, C., Warter, J.M., Laraye, M. Le valproate de sodium: une drogue hyperammonemiante. Etude chez l'epileptique et chez le volontaire sain. J. Neurol. Sci. 1983; 58:195-209.
9. Warter, J.M., Marescaux, C.H., Brandt, C.H., Rumbach, L., Micheletti, G., et al. Sodium valproate associated with phenobarbital: effects of ammonia metabolism in humans. Epilepsia 1983; 24: 628-633.
10. Schmidt, D. Adverse effects of valproate. Epilepsia 1984; 25:544-549.
11. Lortie, A., Chiron, C., Mumford, J., Dulac, O. The potential for increasing seizures frequency, relapse and appearance of new seizures type with vigabatrin. Neurology 1993; 43 (Suppl. 5): s24-s27.
12. Zimmerman, H.J., Ishak, K.G. Valproate-induced hepatic injury. Analysis of 23 fatal cases. Hepatology 1982; 2: 591-597.
13. Rettenmeier, A.W., Prickett, K.S., Gordon, W.P. Studies on biotransformation in the perfused rat liver of 2-n-propil-4-pentenoic acid, a metabolite of antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. Drug Metabolism and Disposition 1985; 13: 81-96.
14. Coulter, D.L., Allen, R.J. Secondary hyperammonemia: a possible mechanism for valproate encephalopathy. The Lancet 1980, 2: 1310-1311.
15. Marini, A.M., Zaret, B.S., Beckner, R. Hepatic and renal contribution to valproic acid-induced hyperammonemia. Neurology 1988; 38: 365-371.
16. Sackellares, C.J., Lee, I.S., Dreifuss, F.E. Stupor following administration of valproic acid to patients receiving other antiepileptic drugs. Epilepsia 1979; 20: 697-703.
17. Pakalnis, A., Drake, M.E., Denio, L. Valproate-Associated Encephalopathy. Journal of Epilepsy 1989; 2:41-44.
18. Mac Donald, R.L. and McLean, M.J., Anticonvulsant drugs: mechanisms of action. In: Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches. (eds A.V. Delgado-Escueta et al.) New York; Raven Press, 1986.
19. Delgado-Escueta, A.V., Ward, A.A. Jr, Woodbury, D.M. and Porter, R.J. New waves of research in epilepsies. In: Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches. (eds A.V. Delgado-Escueta et al.) New York; Raven Press, 1986.
20. De Krom, M.C., Verduin, N., Visser, E., Kleijer, M. Scholtes F and De Groen JHM. Status epilepticus during vigabatrin treatment: a report of three cases. Seizure 1995; 4: 159-162.
21. Leiderman, D.B., Balish, M., Bromfield, E.B., Theodore, W.H. Effect of valproate on human cerebral glucose. Epilepsia 1991; 32; 417-422.
22. Martin, R.L., Lloyd, H.G.E. and Cowan, A.I. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends in Neurosciences 1994; 17; 251-257.
23. Capocchi, G., Cecconi, M., Della Torre, G., Zampolini, M. Synaptic specificity of excitotoxicity in ischemic hippocampal slices. Society for Neuroscience Abstracts 1992; 18; 1362.
24. McNamara, J.O. Excitatory amino acid receptors and epilepsy. Current Opinion in Neurology and Neurosurgery, 1993; 6; 583-587.